FDA Sets Date for Advisory Meeting to Discuss Janssen COVID-19 Vaccine EUA

FDA’s Vaccines and Related Biological Products Advisory Committee will meet on Feb. 26, 2021 to discuss the request for emergency use authorization for Janssen Biotech’s COVID-19 vaccine candidate.